Weiss Multi-Strategy Advisers’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-15,000	Closed	-$614K	–	697
2017 Q3	$614K	Sell	15,000 -14,000	-48%	-$440K	0.02%	411
2017 Q2	$873K	Sell	29,000 -1,000	-3%	-$31.2K	0.04%	376
2017 Q1	$1.08M	Buy	30,000 +2,000	+7%	+$88.2K	0.04%	374
2016 Q4	$1.4M	Hold	28,000	–	–	0.07%	251
2016 Q3	$1.47M	Sell	28,000 -1,160	-4%	-$55.4K	0.09%	253
2016 Q2	$1.21M	Sell	29,160 -10,840	-27%	-$472K	0.09%	245
2016 Q1	$1.63M	Sell	40,000 -15,000	-27%	-$516K	0.07%	289
2015 Q4	$2.28M	Sell	55,000 -10,000	-15%	-$335K	0.16%	159
2015 Q3	$1M	Buy	65,000 +15,000	+30%	+$322K	0.04%	265
2015 Q2	$1.24M	Sell	50,000 -8,000	-14%	-$178K	0.05%	303
2015 Q1	$1.32M	Sell	58,000 -12,000	-17%	-$303K	0.06%	295
2014 Q4	$1.89M	Sell	70,000 -20,000	-22%	-$344K	0.07%	217
2014 Q3	$1.06M	Buy	90,000 +15,000	+20%	+$189K	0.03%	369
2014 Q2	$1.17M	Sell	75,000 -10,000	-12%	-$143K	0.03%	401
2014 Q1	$1.67M	Buy	+85,000	New	+$1.44M	0.03%	385

Other funds holding FPRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Weiss Multi-Strategy Advisers's FPRX Position: Q4 2017 in Review

Weiss Multi-Strategy Advisers sold out of Five Prime Therapeutics, Inc. (FPRX) in Q4 2017, closing a stake of 15,000 shares — an estimated $614K sold.

Weiss Multi-Strategy Advisers first reported a position in FPRX in Q1 2014 and held it in 15 quarters. The position peaked at $2.28M in Q4 2015. 137 funds tracked by Wall St. Rank hold FPRX as of Q4 2017.

Weiss Multi-Strategy Advisers reported no remaining Five Prime Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 15,000 Five Prime Therapeutics, Inc. shares in Q4 2017, an estimated $614K.
Weiss Multi-Strategy Advisers first reported a position in Five Prime Therapeutics, Inc. in Q1 2014 and held it in 15 quarters.
Weiss Multi-Strategy Advisers's Five Prime Therapeutics, Inc. position peaked at $2.28M in Q4 2015.
137 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q4 2017.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.